Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-08-07The Impact of Early Medication Discontinuation on Long-term Clinical Outcome in First Episode Psychosis
-
CLINICAL_TRIALS study record update · 2017-08-04Single-Blind, Randomised, Placebo-controlled First Time in Human Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Escalating Doses of GSK1018921 in Healty Volunteers and a Randomized, Double-blind, Double Dummy, Placebo Controlled, Three-way Crossover Study in a Separate Cohort of Healthy Volunteers to Test the Effect of Single Doses of GSK1018921 and Nicotine on qEEG and MMN in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2017-08-03Open Label Study in Healthy Volunteers to Investigate the Effect of Ketoconazole 400mg on Pharmacokinetics of SB-773812 20mg
-
CLINICAL_TRIALS study record update · 2017-08-02Effect of an NMDA-based Intervention on Biomarker Measures of Cognitive Dysfunction in Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-07-27Evaluation of Metamemory Using a Semantic Construction Strategy in Patients With Schizophrenia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-07-25Randomised Controlled Trial to Evaluate the Efficacy of Cognitive Remediation Within a Secure Forensic Setting for Schizophrenia Spectrum Patients
-
CLINICAL_TRIALS study record update · 2017-07-25Prevention of Weight Gain in Early Psychoses
-
CLINICAL_TRIALS study record update · 2017-07-21Computerized Cognitive Skills Training in Severe Mental Illness
-
CLINICAL_TRIALS study record update · 2017-07-19Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in the Italian Clinical Practice: a Retrospective Cohort, Observational Study
-
CLINICAL_TRIALS study record update · 2017-07-18Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness
-
CLINICAL_TRIALS study record update · 2017-07-18An Adaptive PET Study in Healthy Volunteers Using [11C]GSK931145 to Establish the Relationship of Glycine Transporter 1 Occupancy by GSK1018921 to Plasma Concentrations Over Time.
-
CLINICAL_TRIALS study record update · 2017-07-17Phase 1, Open-Label Positron Emission Tomography (PET) Study to Evaluate D2 Receptor Occupancy Following Single Intravenous Administration of ATI-9242 in Adult Male Healthy Subjects
-
CLINICAL_TRIALS study record update · 2017-07-13Multicenter, Open-label, Two-arm, Parallel-design, Repeat-dose Clinical Trial to Evaluate the PK, Safety, and Tolerability of Four Intramuscular Injections of Risperidone ISM® 75 mg, at 28 Day Intervals in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-07-07A Single-blind, Randomised, Placebo-controlled, Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1144814 in Healthy Male and Female Subjects and an Open-label Positron Emission Tomography Study in Healthy Male Subjects to Evaluate the Neurokinin-1 (NK1) Receptor Occupancy of GSK1144814 in the Living Human Brain Using 11C GR205171.
-
CLINICAL_TRIALS study record update · 2017-07-07The Use of Daily, Intranasal Oxytocin for the Treatment of Childhood-Onset Schizophrenia (COS), a Randomized Double-Blind Trial
-
CLINICAL_TRIALS study record update · 2017-07-02Neuropsychological Evaluation of Psychiatric and Neurological Patients
-
CLINICAL_TRIALS study record update · 2017-07-02Risk Perception in Drug-Dependent Adults With and Without Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-07-02Timing of Voluntary Movement in Patients With Schizophrenia Using EEG and Surface EMG
-
CLINICAL_TRIALS study record update · 2017-07-02fMRI Study of Nicotinic Effect on Neurophysiology of Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-07-02PET Assay of Acetylcholine Beta2* Nicotinic Receptor Density in Smoking and Non-Smoking Schizophrenics
-
CLINICAL_TRIALS study record update · 2017-07-02Effects of Antipsychotics on Eating and Food Craving in People With Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-07-02Investigation of Brain Function During Eyeblink Responding in Normal Volunteers and Patients With Schizophrenia (A Study of Behavior and Evoked Potentials)
-
CLINICAL_TRIALS study record update · 2017-06-28A Multicenter, Open-label, Long-term Safety Study of Aripiprazole (Initial Dose 2 mg/Day, Maintenance Dose 6-24 mg/Day, Maximum Dose 30 mg/Day) Orally Administered Over 52 Weeks in Patients Who Complete a Short-term Treatment Study of Aripiprazole in Pediatric Patients (Aged 13-17 Years) With Schizophrenia (031-09-003 Study)
-
CLINICAL_TRIALS study record update · 2017-06-28A Multicenter, Double-blind, Randomized, Dose-comparison Study of Three Different Doses of Aripiprazole (2 mg/Day, 6-12 mg/Day, 24-30 mg/Day) Orally Administered Over 6 Weeks in Pediatric Patients (Aged 13-17 Years) With Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-06-26A Phase III, Multi-Center, Randomized, 24 Week, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate Efficacy and Safety of RO4917838 in Stable Patients With Persistent, Predominant Negative Symptoms of Schizophrenia Treated With Antipsychotics Followed by a 28 Week, Double-Blind Treatment Period